small molecule

NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)

NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameNITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
Active ingredientNITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
Strength75MG;25MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2017
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.